Stocks and Investing
Stocks and Investing
Thu, May 9, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
John Newman Maintained (TSVT) at Strong Buy with Decreased Target to $11 on, May 9th, 2024
John Newman of Canaccord Genuity, Maintained "2seventy bio, Inc." (TSVT) at Strong Buy with Decreased Target from $12 to $11 on, May 9th, 2024.
John has made no other calls on TSVT in the last 4 months.
There are 4 other peers that have a rating on TSVT. Out of the 4 peers that are also analyzing TSVT, 2 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Nierengarten of "Wedbush" Reiterated at Hold and Held Target at $5 on, Monday, March 18th, 2024
- Yaron Werber of "TD Cowen" Downgraded from Buy to Hold on, Wednesday, January 31st, 2024
These are the ratings of the 2 analyists that currently disagree with John
- Samantha Semenkow of "Citigroup" Maintained at Strong Buy with Increased Target to $12 on, Monday, April 8th, 2024
- Daina Graybosch of "Leerink Partners" Upgraded from Hold to Buy and Increased Target to $18 on, Wednesday, January 31st, 2024
Contributing Sources